Search
Bio-Techne Corp
TECHAdd to Watchlist
72.610USD
+0.040+0.06%
Close 09-25 16:00（ET）
11.31BMarket Cap
102.90P/E TTM
Bio-Techne Corp (TECH) Stock Price Target & Forecast
Analyst Rating
Based on 17 analysts giving stock ratings to Bio-Techne Corp in the past month.
Hold
1 Strong Buy
3 Buy
13 Hold
0 Sell
0 Strong Sell
Target Price
70.267USD-3.23%
TECH Analyst Recommendation Trends
In the current month, TECH has received 3 Buy Ratings, 13 Hold Ratings, and 0 Sell Ratings. TECH average Analyst price target in the last month is 70.268.
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
2026-03
2026-02
1
1
5
5
5
5
5
5
3
3
7
7
7
8
8
8
13
13
5
5
5
4
4
4
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
17
17
17
17
17
17
17
17
TECH Analyst Rating for Peer Comparison
Updated: Sep 27, 2026Company name
Strong Buy
Buy
Hold
Sell
Strong Sell
Analysts
Beigene Ltd
ONC
8
19
0
0
0
27
argenx SE
ARGX
10
13
3
0
0
26
IQVIA Holdings Inc
IQV
7
12
6
0
0
25
Ionis Pharmaceuticals Inc
IONS
6
14
5
0
0
25
Insmed Inc
INSM
7
17
0
0
0
24
Kymera Therapeutics Inc
KYMR
9
12
2
0
0
23
CRISPR Therapeutics AG
CRSP
4
8
10
0
0
22
Revolution Medicines Inc
RVMD
8
13
1
0
0
22
Cytokinetics Inc
CYTK
4
16
2
0
0
22
Tempus AI Inc
TEM
5
6
7
1
1
20
Financial Forecasting
Based on analysts' estimates, TECH EPS is projected to reach 0.441 in FY2027Q1, following reported EPS of 0.350 in FY2026Q4. Track earnings expectations against reported figures to see how profitability is evolving.
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2026Q2
FY2026Q3
FY2026Q4
FY2027Q1
FY2027Q2
Forecast
0.43
0.54
0.52
0.44
0.48
Actual
0.24
0.33
0.35
--
--
Surprise
-44.21%
-39.27%
-32.60%
--
--
FAQs
What is Bio-Techne Corp's expected revenue for the next quarter?
Bio-Techne Corp's expected revenue is 291.77M.
What is Bio-Techne Corp's price target?
Analysts forecast that Bio-Techne Corp's price target is USD 70.27, with the highest forecast at USD 75.00 and the lowest forecast at USD 50.00.
How have Bio-Techne CorpTECH's recent earnings per share performed?
The market expectation was USD 0.35, while Bio-Techne CorpTECH's earnings per share (EPS) for the previous quarter was USD 0.33. EPS for the next quarter is expected at USD 0.44.
What is the analyst rating for Bio-Techne Corp?
Based on the ratings of Bio-Techne Corp's stock from 16 analysts, most analysts support a signal_hold trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as signal_hold. Please note that this is not trading advice. You still need to conduct your own analysis.